Backgroundfor HIV-TB grant:

Uganda has had a generalized HIV epidemic for three decades. Although a number of interventions have been implemented to control the epidemic, the HIV prevalence among adults 15-64 years is estimated at 6.2% and 0.5% among children aged 0-14 years.

The prevalence varies by sex, geographical area and key and/or vulnerable populations; 7.6% females and 4.7% males, 9.8% urban resident women and 6.7% for rural residents. Geographical variation ranges from 3.1% in West Nile to 8.0% in Central (UPHIA, 2016).

These variations in risk and burden have informed proposed interventions, with a focus on populations and regions at high risk to maximize impact of the investments. The Global Fund has been supporting Uganda since 2003 to fight the three diseases (HIV, TB and Malaria). Global Fund has awarded the country another funding opportunity for the period 2018-2020.

The AIDS Support Organization (TASO) was selected by the Uganda Country Coordinating Mechanism (UCCM) to be the second Principal Recipient (PR) of The Global Fund grants to support implementation of HIV-TB activities according to the National HIV strategic Plan 2016/17-2019/20.

It is upon this background that TASO invites Proposals from suitableindigenous Civil Society Organizations (CSOs) to implement the proposed interventions together with District teams and Community Based Organizations (CBOs) in targeted Districts.

ProgramGoals and Impact Indicators:
1. To reduce the number of new youth and adult infections by 70% and number of new paediatric HIV infections by 95% by 2020
2. To decrease HIV-associated morbidity and mortality by 70% through achieving and maintaining 90% viral suppression by 2020
3. To reduce vulnerability to HIV/AIDS and mitigation of its impact on PLHIV and other vulnerable groups 4. To reduce the HIV incidence by 5% by 2019/20: from 234/100,000 in 2015/16 to 222.3/100,000 by 2019/20.

CLICK HERE FOR MORE ON THIS NOTICE